A study identifies NCOA3 as a novel therapeutic target for melanoma
For the first time, the activity of nuclear receptor coactivator 3 (NCOA3) has been shown to promote melanoma development through ultraviolet radiation (UVR) sensitivity regulation, cell cycle prog…
